Where every synthetic peptide starts
Almost every peptide you will read about on this blog, from GLP-1 drugs to copper peptides to the research compounds that fill online stores, starts life the same way. It is built one amino acid at a time, attached to a tiny bead of plastic, in a process invented in the early 1960s.
This series is based on a lab manual: Peptide Synthesis and Applications, volume 1047 of the Methods in Molecular Biology series, edited by Knud J. Jensen, Pernille Tofteng Shelton and Søren L. Pedersen and published in 2013. It is written for chemists. It is full of reagent volumes and reaction times. But hidden inside the protocols is a story most people never hear, and understanding it will change how you think about every peptide product you see.
A short history in four names
The introductory chapter by Knud Jensen lists the milestones.
1901: Emil Fischer reports the synthesis of a peptide. Fischer, one of the founding figures of biochemistry, was the first to deliberately link amino acids together in the lab.
1932: Leonidas Zervas (with Max Bergmann) develops the Cbz protecting group, a chemical "cap" that stops an amino acid reacting in the wrong place. As we will see in Part 2, controlling where amino acids react is the entire game.
1955: Vincent du Vigneaud wins the Nobel Prize in Chemistry for synthesising oxytocin, the nine amino acid hormone involved in childbirth and bonding. It was the first peptide hormone ever made in a lab.
1963: Robert Bruce Merrifield introduces solid-phase peptide synthesis. He wins the 1984 Nobel Prize in Chemistry for it.
The problem Merrifield solved
Before Merrifield, peptides were made in solution. You dissolved two amino acids, joined them, then had to separate the product from everything else in the flask. Then you did it again for the next amino acid. And again. Every step involved purification, and every purification lost material.
For a short peptide that is tedious. For a long one it is nearly impossible.
Merrifield's idea was simple and brilliant. Attach the first amino acid to an insoluble bead. Then add the next amino acid in solution, let it react, and wash everything away. The growing peptide chain stays stuck to the bead. The excess reagents go down the drain. Repeat.
The chapter summarises the three defining features:
- The first building block is anchored to a support that can be filtered.
- Repeated cycles of the same chemical steps (remove the protecting cap, couple the next amino acid) can be performed, including by machine.
- At the end, the finished peptide is released from the support, usually while its remaining protecting groups are removed at the same time.
Because the peptide is stuck to the bead, you can use large excesses of reagents to push each reaction to completion, then simply wash the excess away. That is the key to why it works.
The bead is not really solid
One detail in the chapter surprised me. The term "solid-phase" is a bit misleading. Jensen notes that a more precise name might be "matrix assisted synthesis", because the resins most commonly used are anything but solid.
The standard resin is polystyrene lightly cross-linked, about 1%, so it swells in solvent into something closer to a gel. The chemistry happens inside the swollen bead, not just on its surface. Newer resins graft chains of polyethylene glycol (PEG) throughout the bead, or are made mostly of PEG, which helps with long or difficult sequences.
So when you picture solid-phase synthesis, picture millions of tiny swollen sponges, each one full of growing peptide chains.
From lab bench to ton scale
The chapter makes a point worth knowing. While proteins are generally made by genetically engineered cells (recombinant methods), chemical synthesis remains the dominant way to make peptides, because it is easy, predictable and flexible. It also lets chemists add building blocks that do not exist in nature.
It has been scaled from milligrams in a research lab to ton scale in industry. Many approved peptide drugs are made this way.
What is routine and what is not
Here is the most practical line in the introduction. Peptides up to 15 to 20 amino acids are normally routinely available from companies that make peptides to order. Longer peptides, peptides with unusual amino acids, and peptides with modifications pose challenges.
That is a useful yardstick. A five amino acid peptide is simple chemistry. A 40 amino acid peptide with modifications is a serious undertaking, and the quality of the result depends heavily on the skill and equipment of whoever made it. We will come back to that in Part 4 and Part 7.
Why this matters to you
Most people think of a peptide product as a single substance. Understanding how it is made reveals it is the end result of dozens of chemical steps, each with its own chance of going slightly wrong. The better you understand those steps, the better you can judge the claims made about any peptide, and the more sense the numbers on a certificate of analysis will make.
The next seven parts follow the process from start to finish: the protecting groups, the dangerous acid that older methods need, why long peptides get hard, the chemical "cocktail" that frees the peptide, how chemists check what they made, what purity numbers do not tell you, and how the people who make peptides recommend storing them.
It all starts with a plastic bead.
This series explains laboratory chemistry for general readers. It is not a guide to making or using any compound. Nothing here is medical advice.
